Annonce • 16h
PureCycle Technologies, Inc. Advances Food-Contact PCR Solutions to Support New Jersey’s 2027 Recycled Content Requirement PureCycle Technologies, Inc. has helped brand owners prepare for New Jersey’s upcoming recycled content requirements with a solution that is ready to be used in food-contact packaging applications. Recent confirmation from the New Jersey Department of Environmental Protection (NJDEP) establishes that PureFive resin qualifies as post-consumer recycled content under the state’s Postconsumer Recycled Content Law (P.L. 2021, c.391). A five-year exemption for rigid plastic packaging used in food-contact applications ends in January 2027, when a 20% PCR requirement takes effect. The requirement continues to increase over time, reaching 30% in 2030, 40% in 2033, and 50% in 2036. Food-contact rigid containers incorporating at least 20% PureFive resin have been produced by Amcor, demonstrating that brands can meet New Jersey’s initial recycled content requirement while maintaining functionality and quality. PureFive resin is produced using PureCycle’s patented dissolution recycling process. The technology removes color, odor and contaminants from post-consumer plastic waste to create a high-quality recycled polypropylene with properties similar to virgin material. This makes it suitable for demanding applications such as food-contact packaging, where consistency and reliability are essential. As recycled content mandates expand across the United States, demand for PCR packaging continues to grow. Access to certified PCR from a domestic supplier can help reduce supply risk while supporting more efficient implementation. The NJDEP’s recognition of PureFive resin as qualifying PCR is an important step for brands working to meet New Jersey’s requirements. Further details about PureFive resin, including grades suitable for PCR packaging and food-contact applications, are available through PureCycle’s commercial channels. Actualités en direct • Jun 11
PureCycle Technologies Plans US$395 Million Raise and Unveils High-Content Recycled Film Collaboration PureCycle Technologies plans a $395 million capital raise, split between $250 million in convertible senior notes due 2032 and $145 million in common stock, with options for underwriters to buy additional notes and shares.
The company intends to use most of the proceeds to repurchase a portion of its outstanding 7.25% green convertible notes due 2030, and to fund working capital and general corporate purposes.
In a separate update, PureCycle and Innovia Films reported successful production and trial evaluation of a white, cavitated BOPP film containing more than 40% post-consumer recycled polypropylene using PureCycle’s PureFive Choice resin, which will be marketed to brand owners focused on recycled content.
The capital raise and debt restructuring plan point to an effort to adjust PureCycle’s balance sheet while still funding operations, but the after-hours share price decline highlights investor sensitivity to dilution and leverage.
At the same time, the BOPP film collaboration shows that PureCycle’s resin is being tested in real-world packaging applications, which may be important if you are tracking how its technology is being adopted by brand owners and packaging partners. Actualités en direct • Jun 04
PureCycle Secures ISO Certification and Showcases High-Performance PureFive Resin With Market Response PureCycle received ISO 9001:2015 certification from DQS Global for the Quality Management System at its Ironton, Ohio recycling facility, signaling a formalized approach to process control and product consistency.
The company worked with StackTeck Systems to produce a living hinge cap using up to 100% PureFive recycled polypropylene resin that met mechanical performance standards typically achieved by virgin polypropylene.
Following the announcement, PureCycle’s shares on Nasdaq saw a 6.11% move, reflecting a positive market reaction to the quality and product milestones.
These developments highlight progress on both operational discipline and product validation, which are important for gaining traction with large packaging and consumer goods customers that require consistent, certifiable material performance.
For investors, the next areas to monitor are the pace at which PureCycle translates this technical and certification progress into longer-term supply agreements and the consistency with which the Ironton facility operates under this quality framework. Annonce • Apr 23
PureCycle Technologies, Inc. to Report Q1, 2026 Results on May 06, 2026 PureCycle Technologies, Inc. announced that they will report Q1, 2026 results on May 06, 2026 Annonce • Mar 30
PureCycle Technologies, Inc., Annual General Meeting, May 07, 2026 PureCycle Technologies, Inc., Annual General Meeting, May 07, 2026. Annonce • Mar 27
Purecycle Technologies Signs Eur 40 Million Innovation Fund Grant Agreement with European Climate, Infrastructure and Environment Executive Agency PureCycle Technologies, Inc. announced that it has signed a EUR 40 million grant agreement from the Innovation Fund with the European Climate, Infrastructure and Environment Executive Agency (CINEA) to fund its ‘ASTRA PP’ project in the NextGen District at the Port of Antwerp-Bruges. CINEA announced that a total of 54 projects selected under the Innovation Fund 2024 Call for Net-Zero Technologies have signed their grant agreements. In total, the projects will receive EUR 2,700 million of funding. As part of Project ‘ASTRA PP,’ PureCycle will install a polypropylene (PP) dissolution recycling facility in the Port of Antwerp-Bruges, in Belgium designed for an annual production capacity of 59,000 tonnes (130 million lbs.) of PureFive resin. The project name, ‘ASTRA PP’, pays homage to PureCycle's facility site in the NextGen District and stands for Advanced Solvent-based Technology for Recycling in Antwerp for Polypropylene. The project will contribute to the decarbonization and circularity objectives of the European Green Deal, the Circular Economy Action Plan and the Clean Industrial Deal by providing circular alternatives to conventional fossil-raw-materials for PP production. When completed, the project will provide PureCycle’s customers with solutions for complying with European Union (EU) regulations, such as the recycled content targets in the Packaging & Packaging Waste Regulation (PPWR) and the End-of-Life Vehicles Regulation (ELVR). The Antwerp facility is expected to create positive impacts at an economy-wide level across sectors by providing circular, made-in-Europe PP products that meet the growing customer demand for more sustainable solutions. The ‘ASTRA PP’ project is expected to reach greenhouse gas emission avoidance of 85% relative to conventional fossil-raw-material-based polypropylene production, according to the specific calculation methodology of the Innovation Fund. In addition to signing this grant agreement, PureCycle remains actively engaged with Flanders regional officials and has applied for Flemish regional support for additional funding for the ‘ASTRA PP’ project. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Climate, Infrastructure and Environment Executive Agency (CINEA). Neither the European Union nor the granting authority can be held responsible for them. Annonce • Feb 13
PureCycle Technologies, Inc. to Report Q4, 2025 Results on Feb 26, 2026 PureCycle Technologies, Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026 Board Change • Jan 02
Less than half of directors are independent Following Director Valerie Mars' arrival on 01 January 2026, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Steve Bouck was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annonce • Dec 19
PureCycle Technologies, Inc. Appoints Valerie Mars as Director and Audit and Finance Committee Member, Effective January 1, 2026 On December 18, 2025, the board of directors of PureCycle Technologies, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Valerie Mars as a director of the Company, effective January 1, 2026. Ms. Mars will serve as a member of the Board’s Audit and Finance Committee. Ms. Mars, 66, was from 2000-2024 the Senior Vice President and Head of Corporate Development for Mars Incorporated. Since 2024, Ms. Mars serves as a member of the Board of Directors of the Mars family office, and since December 2021, serves as a member of the board of directors and Audit Committee Chair at Ermenegildo Zegna NV. Ms. Mars previously served on the Board of Directors of Fiat Chrysler Automobiles and Ahlstrom-Munksjo. Ms. Mars received a Master of Business Administration from Columbia Business School and a Bachelor of Arts from Yale University. Ms. Mars is qualified to serve as a director for the Company due to her experience in developing and leading global growth initiatives, financial expertise, and commitment to sustainability. New Risk • Dec 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$195m free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$127m net loss in 3 years). Share price has been volatile over the past 3 months (12% average weekly change). Major Estimate Revision • Nov 13
Consensus EPS estimates upgraded to US$1.13 loss The consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -US$1.27 to -US$1.13 per share. Revenue forecast unchanged from US$22.1m at last update. Chemicals industry in the US expected to see average net income growth of 34% next year. Consensus price target of US$16.33 unchanged from last update. Share price fell 7.0% to US$9.60 over the past week. Annonce • Nov 04
Purecycle Technologies, Inc. Announces Board of Directors Changes On October 28, 2025, the board of directors of PureCycle Technologies, Inc., upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Siri Jirapongphan as a director of the Company, effective October 28, 2025. The Board anticipates naming Dr. Jirapongphan to serve on the Operational Excellence Committee. Dr. Jirapongphan, 71, has served as an independent director of Bangkok Bank PLC, a provider of commercial banking and financial services in Thailand and internationally, since July 2020 and as Chairman of the Audit Committee of Bangkok Bank PLC since April 2022. Additionally, he has served as Director and Treasurer of the Petroleum and Energy Institute of Thailand Foundation, a non-profit organization that supports the upstream oil and gas industry and the downstream petroleum industry in Thailand, since October 2021. From April 2022 through March 2024, Dr. Jirapongphan served as Chairman of the board of directors of IRPC PLC, a petroleum and petrochemical company in Thailand. Further, Dr. Jirapongphan previously served in several roles with public commissions in Thailand and in commercial organizations, including as a member of the board of directors of PTT Global Chemical PLC, a petrochemical and refining company. Dr. Jirapongphan received a Doctor's Degree in Chemical Engineering from Massachusetts Institute of Technology and a Bachelor's Degree in Chemical Engineering (with Honors) from the California Institute of Technology. The Company believes Dr. Jirapongphan is qualified to serve as a director for the Company due to his deep understanding of the Thailand markets, as well as his technical expertise. On October 30, 2025, Jeffrey R. Fieler advised the Company of his decision to resign from the Board effective immediately. Mr. Fieler's decision to resign was not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. In connection with his resignation, the Board agreed to provide for an immediate vesting of Mr. Fieler's 2025 non-employee director grant pro-rated for the six months of the current one-year term on which he served as a director on the Board. Jeffrey R. Fieler stepped down from the Board after more than four years of service. Mr. Fieler also stepped in as PureCycle’s interim Chief Financial Officer for nearly three months in 2024. Annonce • Oct 16
PureCycle Technologies, Inc. Receives REACH Certification, Unlocking EU Sales of Purefive Resin PureCycle Technologies, Inc. announced it has received the REACH Certificate of Compliance, allowing the company to sell PureFive™ resin to customers in the European Union. The REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) Certificate of Compliance confirms that materials handled and produced by PureCycle meet the European Union’s (EU) stringent regulatory requirements for human health and environmental protection.Every substance used in making a product needs to be registered under REACH when the production volume of that product exceeds one ton per year. This regulation also applies in Iceland, Liechtenstein and Norway. PureCycle has plans to build its first European facility at the port of Antwerp in Belgium. This facility is expected to be completed in mid-2028.PureCycle’s flagship dissolution recycling facility in Ironton, Ohio came online in 2023. The Company’s PureFive™ resin from the Ironton Facility has been successfully transformed into various applications, including food packaging, automotive parts and textiles. New Risk • Aug 11
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$195m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$195m free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$116m net loss in 3 years). Share price has been volatile over the past 3 months (11% average weekly change). Revenue is less than US$5m (US$3.2m revenue). Annonce • Jul 25
PureCycle Technologies, Inc. to Report Q2, 2025 Results on Aug 07, 2025 PureCycle Technologies, Inc. announced that they will report Q2, 2025 results on Aug 07, 2025 New Risk • Jun 24
New major risk - Revenue and earnings growth Earnings have declined by 34% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 34% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Revenue is less than US$5m (US$1.6m revenue). Buy Or Sell Opportunity • Jun 17
Now 39% overvalued after recent price rise Over the last 90 days, the stock has risen 76% to US$14.12. The fair value is estimated to be US$10.19, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 171% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 50% per annum. Earnings are also forecast to grow by 42% per annum over the same time period. Annonce • Jun 17
PureCycle Technologies, Inc. announced that it expects to receive $300 million in funding from Duquesne Family Office LLC, Wasserstein Debt Opportunities Management, LP, Samlyn Capital, LLC, Pleiad Investment Advisors Limited, Sylebra Capital Management PureCycle Technologies, Inc announced a private placement to issue 300,000 shares of the Company’s Series B Convertible Perpetual Preferred Stock, par value $0.001 per share at a price of $1000 per share for aggregate gross proceeds of $300,000,000 on June 16, 2025. A holder of the Convertible Preferred Shares may elect to convert such holder’s Convertible Preferred Shares into shares of Common Stock, at any time. The Convertible Preferred Shares are convertible into Common Stock at an initial conversion price equal to $14.02. Convertible Shares will pay cumulative dividends in the amount of 7% per annum, payable in kind or cash at the Company’s option. The transaction is expected to close on June 20, 2025. The transaction will include participation from a series of new and existing Investors including Duquesne Family Office LLC, Wasserstein Debt Opportunities, Samlyn Capital, Pleiad Investment Advisors and Sylebra Capital Management. Major Estimate Revision • May 14
Consensus revenue estimates decrease by 28% The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast fell from US$52.5m to US$38.0m. EPS estimate unchanged from -US$0.52 per share at last update. Chemicals industry in the US expected to see average net income growth of 23% next year. Consensus price target down from US$12.50 to US$10.75. Share price rose 21% to US$7.93 over the past week. Price Target Changed • May 12
Price target decreased by 14% to US$10.75 Down from US$12.50, the current price target is an average from 4 analysts. New target price is 32% above last closing price of US$8.13. Stock is up 54% over the past year. The company is forecast to post a net loss per share of US$0.52 next year compared to a net loss per share of US$1.75 last year. Annonce • Apr 24
PureCycle Technologies, Inc. to Report Q1, 2025 Results on May 07, 2025 PureCycle Technologies, Inc. announced that they will report Q1, 2025 results on May 07, 2025 Annonce • Mar 31
PureCycle Technologies, Inc., Annual General Meeting, May 08, 2025 PureCycle Technologies, Inc., Annual General Meeting, May 08, 2025. New Risk • Mar 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$108m net loss in 3 years). Share price has been volatile over the past 3 months (11% average weekly change). Major Estimate Revision • Mar 06
Consensus revenue estimates fall by 45% The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from US$93.6m to US$52.0m. Forecast losses increased from -US$0.62 to -US$0.848 per share. Chemicals industry in the US expected to see average net income growth of 31% next year. Consensus price target broadly unchanged at US$13.00. Share price was steady at US$9.13 over the past week. New Risk • Mar 02
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: US$289m Forecast net loss in 3 years: US$28m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (US$28m net loss in 3 years). Annonce • Mar 01
United States District Court for the District of Delaware Issues an Order Granting Preliminary Approval to Resolve Shareholder Derivative Lawsuits on Purecycle Technologies, Inc PureCycle Technologies, Inc. announced that on February 18, 2025, the U.S. District Court for the District of Delaware issued an order granting preliminary approval of a settlement to resolve shareholder derivative lawsuits and certain shareholder demand letters. In accordance with the Courts order preliminarily approving the settlement, PureCycle is making disclosure of the settlement to its shareholders in the Notice of Proposed Settlement of Stockholder Derivative Matters, Hearing Thereon, and Right to Appear (Notice) attached hereto. The Notice, along with a copy of the full Stipulation and Agreement of Settlement, can also be found on the investor relations section of PureCycles website at the following web addresses: PureCycle Technologies, Inc. Breakeven Date Change • Feb 27
No longer forecast to breakeven The 5 analysts covering PureCycle Technologies no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$39.8m in 2027. New consensus forecast suggests the company will make a loss of US$13.2m in 2027. Price Target Changed • Feb 13
Price target increased by 15% to US$13.10 Up from US$11.40, the current price target is an average from 5 analysts. New target price is 49% above last closing price of US$8.81. Stock is up 79% over the past year. The company is forecast to post a net loss per share of US$1.57 next year compared to a net loss per share of US$0.62 last year. Annonce • Feb 12
PureCycle Technologies, Inc. to Report Q4, 2024 Results on Feb 27, 2025 PureCycle Technologies, Inc. announced that they will report Q4, 2024 results on Feb 27, 2025 Annonce • Nov 14
PureCycle Technologies, Inc. announced delayed 10-Q filing On 11/13/2024, PureCycle Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Major Estimate Revision • Nov 13
Consensus revenue estimates decrease by 62%, EPS upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from US$17.5m to US$6.57m. EPS estimate increased from -US$1.24 to -US$1.22 per share. Chemicals industry in the US expected to see average net income growth of 28% next year. Consensus price target up from US$8.80 to US$11.40. Share price fell 12% to US$11.79 over the past week. Price Target Changed • Nov 11
Price target increased by 19% to US$10.00 Up from US$8.38, the current price target is an average from 5 analysts. New target price is 23% below last closing price of US$12.91. Stock is up 322% over the past year. The company is forecast to post a net loss per share of US$1.20 next year compared to a net loss per share of US$0.62 last year. Annonce • Oct 24
PureCycle Technologies, Inc. to Report Q3, 2024 Results on Nov 07, 2024 PureCycle Technologies, Inc. announced that they will report Q3, 2024 results on Nov 07, 2024 New Risk • Oct 18
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: US$154m Forecast net loss in 3 years: US$16m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Revenue is less than US$1m. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (US$16m net loss in 3 years). Major Estimate Revision • Aug 15
Consensus revenue estimates fall by 44% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from US$35.0m to US$19.6m. Forecast losses increased from -US$1.02 to -US$1.25 per share. Chemicals industry in the US expected to see average net income growth of 40% next year. Consensus price target up from US$8.38 to US$9.20. Share price fell 7.4% to US$5.84 over the past week. New Risk • Aug 12
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 2 years. Trailing 12-month net loss: US$154m Forecast net loss in 2 years: US$69m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$188m free cash flow). Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$69m net loss in 2 years). Share price has been volatile over the past 3 months (10% average weekly change). Price Target Changed • Aug 12
Price target increased by 13% to US$9.50 Up from US$8.38, the current price target is an average from 4 analysts. New target price is 68% above last closing price of US$5.64. Stock is down 48% over the past year. The company is forecast to post a net loss per share of US$1.18 next year compared to a net loss per share of US$0.62 last year. Price Target Changed • Aug 02
Price target increased by 7.4% to US$8.38 Up from US$7.80, the current price target is an average from 4 analysts. New target price is 19% above last closing price of US$7.03. Stock is down 36% over the past year. The company is forecast to post a net loss per share of US$1.02 next year compared to a net loss per share of US$0.62 last year. Annonce • Jul 26
PureCycle Technologies, Inc. to Report Q2, 2024 Results on Aug 08, 2024 PureCycle Technologies, Inc. announced that they will report Q2, 2024 results on Aug 08, 2024 New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$241m free cash flow). Revenue is less than US$1m. Minor Risk Share price has been volatile over the past 3 months (10% average weekly change). Annonce • Jul 01
Pomerantz LLP Announces Propose Class Action Settlement on Behalf of Purchasers of Securities of PureCycle Technologies, Inc Pomerantz LLP announced that the United States District Court for the Middle District of Florida has approved the following announcement of a proposed class action settlement that would benefit purchasers of securities of PureCycle Technologies, Inc.: Summary notice of pendency and proposed settlement of class action and final approval hearing: All persons who purchased or otherwise acquired purecycle securities1 between November 16, 2020 and November 10, 2021, both dates inclusive. Pursuant to an Order of the United States District Court for the Middle District of Florida, that a hearing will be held on October 8, 2024, at 10:00 a.m. before the Honorable Paul G. Byron, United States District Judge of the Middle District of Florida, 401 West Central Boulevard, Courtroom 4B, Orlando, Florida 32801, for the purpose of determining: (1) whether the proposed Settlement of the claims in the above-captioned Action for consideration including the sum of $12,000,000 should be approved by the Court as fair, reasonable, and adequate; (2) whether the proposed plan to distribute the Settlement proceeds is fair, reasonable, and adequate; (3) whether the application of Lead Counsel for an award of attorneys’ fees of up to one-third of the Settlement Amount ($4,000,000) plus interest, reimbursement of expenses of not more than $400,000, and a Compensatory Award to Lead Plaintiffs of no more than $60,000 collectively (or $30,000 each) should be approved; and (4) whether this Action should be dismissed with prejudice as set forth in the Stipulation of Settlement dated May 6, 2024 (the Settlement Stipulation). Annonce • Jun 13
PureCycle Technologies, Inc. Receives Expanded FDA No Objection Letter for PureFive Resin Use in Cosmetics, Personal Care and Food Applications PureCycle Technologies, Inc. announced the receipt of a Letter of No Objection from the United States Food & Drug Administration (FDA) confirming that the Company's PureFive Ultra-Pure Recycled resin is suitable for use in food-contact applications. This LNO expands upon a previous no-objection letter to PureCycle from the FDA, confirming that the Agency considers PureFive Ultra-Pure Recycled resin to be suitably pure for use in contact with all food types under FDA's Conditions of Use A through H. This expansion provides PureCycle with the same Conditions of Use for PureFive recycled resin as virgin polypropylene. The Conditions of Use span from frozen food storage to microwaveable packaging. The FDA's LNO acknowledges that PureCycle may procure a wider range of feedstock for FDA applications, including curbside materials that are sorted for food-grade. Currently, the Company purchases both food-grade and non-food grade feedstocks for the purification operations. The Company previously received an LNO for all food types under Conditions of Use E through G with only food-grade post-consumer recycled feedstock that was collected at stadiums and other point sources. This is the result of months of feed preparation and purification through PureCycle's Feedstock Evaluation Unit, sample-gathering and an extensive component challenge-testing in preparation for the final submission. The Company also previously received an LNO for all food types under Conditions of Use A-H with the use of food-grade post-industrial recycled materials. PureCycle uses a patented recycling process to remove color, odor, and other impurities from polypropylene plastic waste. Annonce • Mar 30
Purecycle Technologies, Inc. Announces Scheduled Operational Pause At Ironton Purification Facility PureCycle Technologies, Inc. announced that its flagship purification facility in Ironton, Ohio will begin a scheduled operational pause on April 1, 2024. During the pause, several improvements will be made to the facility with the goal of increasing reliability and driving more consistent product quality. The operational pause is expected to last approximately two to four weeks. PureCycle currently plans to provide an update on the outcome of the pause during the company's next corporate update in May. Annonce • Mar 29
PureCycle Technologies, Inc., Annual General Meeting, May 08, 2024 PureCycle Technologies, Inc., Annual General Meeting, May 08, 2024, at 10:00 US Eastern Standard Time. Agenda: To elect the seven (7) Directors proposed veach to serve for a one-year term; to ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; to consider the named executive officer compensation; and Transact any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof. Annonce • Mar 02
PureCycle Technologies, Inc. announced delayed annual 10-K filing On 02/29/2024, PureCycle Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. Annonce • Feb 20
Purecycle Technologies, Inc. Announces CFO Changes PureCycle Technologies, Inc. announced the appointment of Jaime Vasquez as the company's new Chief Financial Officer. Vasquez brings more than 20 years of experience as a financial executive to the role and most recently served as Chief Financial Officer at C&D Technologies. Prior to his time with C&D Technologies, Vasquez served as Chief Financial Officer at AK steel from 2015 to 2019, and previously as Director of Finance from 2014 through 2015. From 2001 through 2014, Vasquez worked in various financial roles at Carpenter Technology Corporation. Vasquez will replace Jeff Fieler, who has served as interim Chief Financial Officer since December 1, 2023. Fieler will continue to serve as a non-independent member of the PureCycle Board of Directors. Annonce • Feb 08
PureCycle Technologies, Inc. to Report Q4, 2023 Results on Feb 29, 2024 PureCycle Technologies, Inc. announced that they will report Q4, 2023 results on Feb 29, 2024 Annonce • Dec 07
PureCycle Technologies, Inc. Resumes Pellet Production At Ironton Purification Facility PureCycle Technologies, Inc. has resumed pellet production at its flagship purification facility in Ironton, Ohio, following a scheduled pause to upgrade the plant. One of the most important improvements was the installation of an automatic screen changer on the final product extruder. The screen changer will help improve run times and enhance the production of PureCycle's PureFive Ultra-Pure Recycled resin. Over the Thanksgiving holiday, the Ironton maintenance outage was completed and the restart process was initiated. The restart process included time to unwind the maintenance activities, recharge the solvent and restart the plant. Feedstock was delivered on Sunday and pellet production resumed on Monday. The restart took a few days longer than expected, due predominantly to delayed electrical component deliveries. At full capacity, PureCycle'sIronton facility is expected to produce 107 million pounds of PureFive UPR resin per year. Major Estimate Revision • Dec 05
Consensus revenue estimates fall by 33% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$10.7m to US$7.19m. Forecast losses increased from -US$0.593 to -US$0.60 per share. Chemicals industry in the US expected to see average net income growth of 18% next year. Consensus price target down from US$9.90 to US$8.60. Share price rose 4.2% to US$3.99 over the past week. Annonce • Dec 02
Purecycle Technologies, Inc. Announces Chief Financial Officer Changes PureCycle Technologies, Inc. announced Jeff Fieler will take over as the Company's interim Chief Financial Officer, following the resignation of Larry Somma. A search for Somma's permanent replacement is underway. Fieler has served as an independent member of the PureCycle Board of Directors since March 2021. He is currently a Senior Advisor of Sylebra Capital Management and has more than 20 years of experience in the financial industry. Major Estimate Revision • Nov 16
Consensus revenue estimates decrease by 48%, EPS upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from US$20.8m to US$10.7m. EPS estimate increased from -US$0.788 to -US$0.593 per share. Chemicals industry in the US expected to see average net income growth of 16% next year. Consensus price target down from US$14.92 to US$9.90. Share price rose 36% to US$4.21 over the past week. Recent Insider Transactions • Nov 16
CEO & Director recently bought US$220k worth of stock On the 10th of November, Dustin Olson bought around 68k shares on-market at roughly US$3.22 per share. This transaction amounted to 31% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Dustin has been a buyer over the last 12 months, purchasing a net total of US$212k worth in shares. New Risk • Nov 15
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$294m free cash flow). Share price has been highly volatile over the past 3 months (16% average weekly change). Revenue is less than US$1m. Minor Risk Currently unprofitable and not forecast to become profitable over next 3 years (US$75m net loss in 3 years). Price Target Changed • Nov 10
Price target decreased by 14% to US$11.70 Down from US$13.58, the current price target is an average from 5 analysts. New target price is 247% above last closing price of US$3.37. Stock is down 53% over the past year. The company is forecast to post a net loss per share of US$0.72 next year compared to a net loss per share of US$0.54 last year. Annonce • Oct 29
Levi & Korsinsky Notifies Purecycle Technologies, Inc. Investors of A Class Action Lawsuit Levi & Korsinsky, LLP notifies investors in PureCycle Technologies, Inc. of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of PureCycle investors who were adversely affected by alleged securities fraud between August 8, 2023 and September 13, 2023. Follow the link below to get more information and be contacted by a member of the team: CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Ironton Facility experienced a full plant power outage on August 7, 2023; (2) there was a risk of additional failures resulting from the August 7, 2023 power outage; and (3) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Annonce • Oct 24
PureCycle Technologies, Inc. to Report Q3, 2023 Results on Nov 08, 2023 PureCycle Technologies, Inc. announced that they will report Q3, 2023 results on Nov 08, 2023 Annonce • Oct 01
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of PureCycle Technologies, Inc. (PCT) Investors Law Offices of Howard G. Smith announced that a class action lawsuit has been filed on behalf of investors who purchased PureCycle Technologies, Inc. securities between August 8, 2023 and September 13, 2023, inclusive. PureCycle investors have until November 28, 2023to file a lead plaintiff motion. On September 13, 2023, after the market closed, PureCycle disclosed that its Ironton Facility experienced a full plant power outage on August 7, 2023, which required the Ironton Facility to halt operations. The Company further disclosed that it replaced a seal that purportedly failed as a result of the power outage, and initiated facility restart procedures on September 11, 2023. On this news, PureCycle’s stock price fell $1.395, or 18.4%, to close at $6.18 per share on September 14, 2023, on unusually heavy trading volume. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Ironton Facility experienced a full plant power outage on August 7, 2023; (2) that there was a risk of additional failures resulting from the August 7, 2023 power outage; and (3) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Major Estimate Revision • Sep 15
Consensus revenue estimates fall by 16% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$24.7m to US$20.8m. Forecast losses increased from -US$0.774 to -US$0.796 per share. Chemicals industry in the US expected to see average net income growth of 18% next year. Consensus price target of US$14.92 unchanged from last update. Share price fell 28% to US$6.18 over the past week. Major Estimate Revision • Aug 15
Consensus revenue estimates fall by 39% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$40.6m to US$24.7m. Forecast losses increased from -US$0.453 to -US$0.766 per share. Chemicals industry in the US expected to see average net income growth of 17% next year. Consensus price target up from US$13.58 to US$14.92. Share price was steady at US$10.38 over the past week. New Risk • Aug 11
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: US$127m Forecast net loss in 3 years: US$4.4m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$355m free cash flow). Revenue is less than US$1m. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$4.4m net loss in 3 years). Share price has been volatile over the past 3 months (11% average weekly change). Price Target Changed • Aug 10
Price target increased by 15% to US$14.92 Up from US$12.92, the current price target is an average from 6 analysts. New target price is 39% above last closing price of US$10.75. Stock is up 14% over the past year. The company is forecast to post a net loss per share of US$0.75 next year compared to a net loss per share of US$0.54 last year. Annonce • Jul 22
PureCycle Technologies, Inc. to Report Q2, 2023 Results on Aug 09, 2023 PureCycle Technologies, Inc. announced that they will report Q2, 2023 results on Aug 09, 2023 Price Target Changed • Jul 14
Price target increased by 9.4% to US$13.58 Up from US$12.42, the current price target is an average from 6 analysts. New target price is 31% above last closing price of US$10.33. Stock is up 50% over the past year. The company is forecast to post a net loss per share of US$0.48 next year compared to a net loss per share of US$0.54 last year. Board Change • Jun 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. CEO & Director Dustin Olson was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • May 16
Consensus revenue estimates fall by 20% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$57.4m to US$46.1m. Forecast losses increased from -US$0.437 to -US$0.476 per share. Chemicals industry in the US expected to see average net income growth of 15% next year. Consensus price target of US$12.42 unchanged from last update. Share price fell 8.2% to US$6.81 over the past week. Recent Insider Transactions Derivative • May 15
Independent Director notifies of intention to sell stock Timothy Glockner intends to sell 640k shares in the next 90 days after lodging an Intent To Sell Form on the 12th of May. If the sale is conducted around the recent share price of US$7.97, it would amount to US$5.1m. Timothy currently holds 6.43m shares (0.03930970767518959 of the company). There has only been one transaction (US$7.6k sale) from insiders over the last 12 months. Price Target Changed • Nov 16
Price target decreased to US$13.50 Down from US$16.33, the current price target is an average from 6 analysts. New target price is 106% above last closing price of US$6.55. Stock is down 46% over the past year. The company is forecast to post a net loss per share of US$0.63 next year compared to a net loss per share of US$0.75 last year. Price Target Changed • Nov 12
Price target decreased to US$14.17 Down from US$16.33, the current price target is an average from 6 analysts. New target price is 107% above last closing price of US$6.84. Stock is down 28% over the past year. The company is forecast to post a net loss per share of US$0.64 next year compared to a net loss per share of US$0.75 last year. Major Estimate Revision • Aug 18
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from US$3.83m to US$1.77m. EPS estimate increased from -US$0.65 to -US$0.51 per share. Chemicals industry in the US expected to see average net income growth of 25% next year. Consensus price target broadly unchanged at US$16.60. Share price rose 5.2% to US$9.75 over the past week. Board Change • Aug 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Dan Coombs was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Jul 02
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Dan Coombs was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions Derivative • Jun 25
Director notifies of intention to sell stock John Scott intends to sell 460k shares in the next 90 days after lodging an Intent To Sell Form on the 21st of June. If the sale is conducted around the recent share price of US$8.50, it would amount to US$3.9m. Since June 2021, John's direct individual holding has increased from 2.72m shares to 2.73m. Company insiders have collectively bought US$264k more than they sold, via options and on-market transactions, in the last 12 months. Price Target Changed • May 28
Price target decreased to US$19.00 Down from US$20.83, the current price target is an average from 5 analysts. New target price is 104% above last closing price of US$9.30. Stock is down 47% over the past year. The company is forecast to post a net loss per share of US$0.65 next year compared to a net loss per share of US$0.75 last year. Major Estimate Revision • May 28
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from US$5.27m to US$4.69m. EPS estimate increased from -US$0.67 to -US$0.65 per share. Chemicals industry in the US expected to see average net income growth of 23% next year. Consensus price target down from US$20.83 to US$19.00. Share price fell 2.2% to US$9.30 over the past week. Recent Insider Transactions Derivative • May 27
Executive Officer notifies of intention to sell stock David Brenner intends to sell 50k shares in the next 90 days after lodging an Intent To Sell Form on the 20th of May. If the sale is conducted around the recent share price of US$9.75, it would amount to US$488k. Since June 2021, David's direct individual holding has decreased from 998.11k shares to 723.19k. Company insiders have collectively bought US$394k more than they sold, via options and on-market transactions, in the last 12 months. Major Estimate Revision • May 19
Consensus revenue estimates fall by 20% The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$6.61m to US$5.27m. Forecast losses increased from -US$0.48 to -US$0.67 per share. Chemicals industry in the US expected to see average net income growth of 21% next year. Consensus price target broadly unchanged at US$20.83. Share price rose 46% to US$9.22 over the past week. Price Target Changed • Apr 27
Price target decreased to US$21.00 Down from US$22.58, the current price target is an average from 5 analysts. New target price is 166% above last closing price of US$7.90. Stock is down 71% over the past year. The company is forecast to post a net loss per share of US$0.48 next year compared to a net loss per share of US$0.75 last year. Major Estimate Revision • Apr 15
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 losses forecast to reduce from -US$0.58 to -US$0.48 per share. Revenue forecast unchanged from US$2.03m at last update. Chemicals industry in the US expected to see average net income growth of 21% next year. Consensus price target of US$21.00 unchanged from last update. Share price rose 16% to US$8.54 over the past week. Breakeven Date Change • Mar 30
No longer forecast to breakeven The 5 analysts covering PureCycle Technologies no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$108.4m in 2024. New consensus forecast suggests the company will make a loss of US$9.56m in 2024. Annonce • Mar 06
PureCycle Technologies, Inc. to Report Q4, 2021 Results on Mar 09, 2022 PureCycle Technologies, Inc. announced that they will report Q4, 2021 results on Mar 09, 2022 Breakeven Date Change • Jan 02
Forecast to breakeven in 2024 The 4 analysts covering PureCycle Technologies expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$66.2m in 2024. Average annual earnings growth of 69% is required to achieve expected profit on schedule. Recent Insider Transactions • Nov 19
Insider recently bought US$75k worth of stock On the 15th of November, Michael Dee bought around 7k shares on-market at roughly US$10.47 per share. In the last 3 months, they made an even bigger purchase worth US$89k. Insiders have collectively bought US$493k more in shares than they have sold in the last 12 months. 